Aurlumyn
Payments companies reported to CMS as associated with Aurlumyn. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aurlumyn, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aurlumyn
These are the largest totals companies reported as associated with Aurlumyn. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ken Zafren | Stanford, CA | Emergency Medicine | $9,000.00 |
| Bruce Friedman | Augusta, GA | Critical Care Medicine (Internal Medicine) | $6,783.14 |
| Fariborz Rezai | Livingston, NJ | Critical Care Medicine (Internal Medicine) | $900.00 |
| Jennifer Dow | Anchorage, AK | Emergency Medicine | $877.75 |
| William Peacock | Houston, TX | Emergency Medicine | $675.00 |
| Lee Faucher | Madison, WI | Trauma Surgery | $675.00 |
| Joshua Goldstein | Boston, MA | Emergency Medicine | $675.00 |
| Graham Brant-Zawadzki | Oakland, CA | Emergency Medicine | $675.00 |
| Robert Takla | Southfield, MI | Emergency Medicine | $675.00 |
| Christopher Baugh | Boston, MA | Emergency Medicine | $675.00 |
Prescribed Aurlumyn?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.